Phase I/II trial of low dose suramin (CI-1003, NSC#34936) and 5-fluorouracil in patients with metastatic renal cell carcinoma (RCC).

Trial Profile

Phase I/II trial of low dose suramin (CI-1003, NSC#34936) and 5-fluorouracil in patients with metastatic renal cell carcinoma (RCC).

Completed
Phase of Trial: Phase I/II

Latest Information Update: 29 May 2015

At a glance

  • Drugs Suramin sodium (Primary) ; Fluorouracil
  • Indications Renal cancer
  • Focus Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 11 May 2008 The expected completion date for this trial is now 1 Mar 2008.
    • 11 May 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
    • 10 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top